Guardian Pharmacy Services, Inc.
GRDN
$26.03
-$0.20-0.76%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 344.33M | 329.31M | 338.57M | 314.39M | 300.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 344.33M | 329.31M | 338.57M | 314.39M | 300.04M |
| Cost of Revenue | 276.19M | 264.96M | 271.47M | 253.52M | 238.75M |
| Gross Profit | 68.15M | 64.35M | 67.10M | 60.88M | 61.29M |
| SG&A Expenses | 53.07M | 51.05M | 45.91M | 165.49M | 42.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 329.26M | 316.01M | 317.37M | 419.01M | 281.20M |
| Operating Income | 15.08M | 13.30M | 21.20M | -104.61M | 18.84M |
| Income Before Tax | 12.59M | 13.11M | 16.22M | -105.64M | 5.22M |
| Income Tax Expenses | 3.76M | 3.83M | 4.38M | 176.00K | -- |
| Earnings from Continuing Operations | 8.83M | 9.27M | 11.84M | -105.82M | 5.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 203.00K | 175.00K | 102.00K | -6.82M | -5.22M |
| Net Income | 9.03M | 9.45M | 11.94M | -112.64M | 0.00 |
| EBIT | 15.08M | 13.30M | 21.20M | -104.61M | 18.84M |
| EBITDA | 20.57M | 18.57M | 26.35M | -99.62M | 23.71M |
| EPS Basic | 0.15 | 0.15 | 0.19 | -2.00 | -- |
| Normalized Basic EPS | 0.16 | 0.14 | 0.21 | -1.19 | 0.10 |
| EPS Diluted | 0.14 | 0.15 | 0.19 | -2.00 | -- |
| Normalized Diluted EPS | 0.15 | 0.14 | 0.21 | -1.19 | 0.10 |
| Average Basic Shares Outstanding | 62.05M | 62.04M | 62.04M | 61.14M | 61.14M |
| Average Diluted Shares Outstanding | 63.20M | 62.91M | 62.72M | 61.14M | 61.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -10.93% | -- |